FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

330201000001102: Sodium cromoglicate compound 2% nasal spray - product

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    11574501000001113 Sodium cromoglicate compound 2% nasal spray - product en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    12335801000001112 Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    12335901000001118 Sodium cromoglycate compound 2% nasal spray en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    12559201000001113 Sodium cromoglicate compound 2% nasal spray - product en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    61196601000001112 Sodium cromoglicate compound 2% nasal spray en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Is a Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray false Inferred relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Availability Available only as a proprietary false Additional relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Legal category Pharmacy Medicine false Additional relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Product name type Generic name false Additional relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Has active ingredient Xylometazoline hydrochloride false Inferred relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Has active ingredient Substance with mast cell stabilizer mechanism of action (substance) false Inferred relationship Existential restriction modifier
    Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Has active ingredient Cromoglicate sodium false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Resiston One nasal spray Is a False Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Inferred relationship Existential restriction modifier
    Rynacrom Compound nasal spray Is a False Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Inferred relationship Existential restriction modifier
    Rynacrom Allergy nasal spray Is a False Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start